Aiming to rectify noise-induced hearing loss, Frequency Therapeutics has begun financing for a small-molecule therapy which will help re-grow small hairs within the inner ear. This therapy is designed to mimic CRISPR and gene therapies to stimulate remaining cells into producing smaller hair cells. If approved by the FDA, Frequency Therapeutics would have commercialization of the first small-molecule hearing loss treatment. Read the full press release here.